Rhapsido®▼ (remibrutinib)
Where can I get more information about remibrutinib?
More information
United Kingdom (UK) Summary of Product Characteristics (SmPC) for remibrutinib
United Kingdom (UK) Patient Information Leaflet (PIL) for remibrutinib
These links will take you to the electronic medicines compendium (emc) website, which is a non-Novartis website.
UK | September 2026 | FA-11723546
Reporting side-effects
If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side-effects not listed in the information leaflet that comes in the pack. ▼ The medicine referred to in this material is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side-effects you may get. Please see www.mhra.gov.uk/yellowcard. for instructions on how to report side-effects.